Concepedia

Author

Désirée van der Heijde

Leiden University Medical Center

Also Known As

Alfredo Morabia, Desiree Van Der Heijde, Desiree van der Heijde, Desireé van der Heijde, Desirée van der Heijde, DÉSIRÉE van der HEIJDE, Désirée Van Der Heijde, Désirée van der Heijde, Heijde, D. van der, van der Heijde, Desiree

89

Publications

5.5K

Citations

33

H-Index

56

Concepts

All Affiliations

Leiden University Medical CenterMaastricht University Medical CentreMaastricht UniversityUniversité Paris CitéHôpital Cochin
DV

About

Désirée van der Heijde is an author at Leiden University Medical Center specializing in medicine, orthopaedics, and osteoarthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

1.2K

2

Health Sciences

6

6

421

3

Engineering

1

1

77

4

Public Health

1

1

18

5

Applied Physiology

1

1

37

Désirée van der Heijde

×

44

Publications

5.2K

Citations

32

H-Index

YearCitations

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

David T. Felson, Josef S Smolen, George A. Wells,

Annals of the Rheumatic Diseases

2011

754

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

Jennifer J. Anderson, Gabriel Baron, Désirée van der Heijde,

Arthritis & Rheumatism

2001

608

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Christopher P. Cannon, Sean Curtis, Garret A. FitzGerald,

The Lancet

2006

520

Low‐dose prednisolone in addition to the initial disease‐modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two‐year randomized trial

Björn Svensson, Annelies Boonen, Kristina Albertsson,

Arthritis & Rheumatism

2005

344

Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria.

Thao Pham, Désirée van der Heijde, Marissa Lassere,

PubMed

2003

261

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty‐two–week, randomized, controlled study

Désirée van der Heijde, Herbert S. B. Baraf, César Ramos-Remus,

Arthritis & Rheumatism

2005

229

Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.

Florence Tubach, Philippe Ravaud, Dorcas Beaton,

PubMed

2007

193

The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.

Erik de Klerk, Désirée van der Heijde, R. Landewé,

PubMed

2003

186

Association of baseline levels of markers of bone and cartilage degradation with long‐term progression of joint damage in patients with early rheumatoid arthritis

Patrick Garnero, Robert Landewé, Maarten Boers,

Arthritis & Rheumatism

2002

182

Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes

Robert Landewé, Désirée van der Heijde, Lars Klareskog,

Arthritis & Rheumatism

2006

179

Page 1